Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
Palo Alto Networks Reports Fiscal Fourth Quarter and Fiscal Year 2026 Financial Results
-
Phillips Edison & Company Raises Monthly Dividend
-
GitLab Reports Second Quarter Fiscal Year 2027 Financial Results
-
RED ROBIN GOURMET BURGERS, INC., COMPLETES SALE OF 108 RESTAURANTS FOR $89.4 MILLION
-
Credo Technology Group Holding Ltd Reports First Quarter of Fiscal Year 2027 Financial Results
-
INOVIO to Participate in Upcoming Investor Conferences
-
Exelixis to Webcast Fireside Chats as Part of Upcoming Investor Conferences in September
-
Terra Clean Energy Corp. Engages Independent Trading Group as Market Maker
-
Shoulder Innovations to Participate in the Morgan Stanley 24th Annual Healthcare Conference
-
Chegg Announces Full Repayment of Convertible Notes
-
Myomo to Present at the H.C. Wainwright 28th Annual Global Investment Conference
-
Rocket Companies President and CFO Brian Brown to Present at Barclays Global Financial Services Conference
-
Rubrik and CrowdStrike Bring Agentic Automation to Identity Attack Resilience
-
FIGS Announces Participation in the Barclays 19th Annual Global Consumer Conference
-
Quantum Appoints Hiral A. Patel as Chief Accounting Officer
-
AAR announces participation in 2026 Jefferies Global Industrials Conference
-
F5 to Participate in Upcoming Financial Conference
-
Cytek Biosciences to Participate in Upcoming Investor Conferences
-
Tantech Holdings Ltd. Announces Reverse Split Record Date
-
WHP Global and G-III Apparel Group Complete Acquisition of Marc Jacobs
-
Bitdeer Announces Acquisition of 200 Acres Near Rockdale Facility in Milam County, Texas to Support AI/HPC Infrastructure Development
-
Root Insurance and Carvana Extend Embedded Insurance Agreement
-
Veracyte to Participate in the Morgan Stanley 24th Annual Global Healthcare Conference
-
Phillips Edison & Company Raises Monthly Dividend
-
Astera Labs to Participate in the Citi 2026 Global TMT Conference
-
Alamar Biosciences to Participate in Morgan Stanley 24th Annual Global Healthcare Conference
-
EuroHoldings Ltd. Announces Charter Contract Extensions for Two of its Feeder Containerships, M/V Joanna and M/V Aegean Express
-
BBOT to Participate in Upcoming Investor Healthcare Conferences
-
Candel Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
Ultragenyx Announces the Publication of a Successful 96-Week Randomized, Placebo-Controlled Trial with Crossover Treatment of GENGLYCOS™ (also known as DTX401) AAV Gene Therapy in GSDIa in The Journ
-
Lexicon Pharmaceuticals to Participate at Three Upcoming Investor Conferences
-
CAMP4 to Participate in Upcoming Investor Conferences
-
Greenlight Capital Re, Ltd. Announces New Director Appointments
-
Pulmonx Corporation Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
Sana Biotechnology to Present at September 2026 Investor Conferences
-
Adaptive Biotechnologies to Participate in the Morgan Stanley 24th Annual Global Healthcare Conference
-
Black Pastors to Rally at DNC and Third Way Offices, Demanding "Substance Over Symbolism"
-
Jones Ventures INTL Acquisition1 Corp Announces the Separate Trading of its Class A Ordinary Shares and Rights, Commencing September 3, 2026
-
VINCI COMPASS COMPLETES THE ACQUISITION OF NAVI'S REAL ESTATE PLATFORM
-
Octave Bioscience Names Jennifer Mellum Vice President of Marketing as Precision Neurology Platform Scales
-
Canadian Securities Exchange Welcomes Listing of Pelican AI, Trading Under Symbol "PEL"
-
COLLPLANT ANNOUNCES REVERSE SHARE SPLIT
-
Thornburg Income Builder Opportunities Trust Announces Distribution
-
Sprouts Farmers Market, Inc. Announces CEO Succession
-
Ionetix Begins Shipping Astatine-211 to Support Preclinical and Clinical Trials
-
Liberty Global Schedules Investor Call for Third Quarter 2026 Results
-
Arvinas Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
-
Mannatech Announces Retirement of J. Stanley Fredrick from the Board and Appointment of Robert Toth as Chairman of the Board
-
ARS Pharmaceuticals to Participate in Upcoming Investor Conferences
